share_log

中國再生醫學:終止(1)建議遷冊;(2)建議採納存續大綱及新細則;(3)建議減少股份溢價賬;(4)建議股本重組;及(5)建議變更每手買賣單位

CRMI: TERMINATION OF (1) PROPOSED CHANGE OF DOMICILE; (2) PROPOSED ADOPTION OF MEMORANDUM OF CONTINUANCE AND NEW BYE-LAWS; (3) PROPOSED REDUCTION OF SHARE PREMIUM ACCOUNT; (4) PROPOSED CAPITAL REORGANISATION; AND (5) PROPOSED CHANGE IN BOARD LOT SIZE

Nov 27, 2020 05:13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more